The study, which was conducted in 11 countries, marks an important global advancement in natural anti-obesity solutions and offers new hope for many patients
So what is actually happening behind the scenes
K.ChenC
The mechanism work on this is active: GLP-1R is expressed in cardiovascular tissue, and receptor activation there appears to modulate inflammation, endothelial function, and possibly plaque biology through pathways that are not obviously downstream of insulin or appetite regulation
The simplest difference is this: weekly GLP-1 injections are typically chosen for patients who want a more traditional, structured, once-weekly treatment routine , while daily GLP-1 ODTs may appeal to patients who prefer to avoid injections and want a needle-free option that fits into a daily habit
Yagublu V, Karimova A, Hajibabazadeh J, Reissfelder C, Muradov M, Bellucci S, et al